Overview

To evaluate whether a digital support and communication platform for COPD patients after 6 months provides:

1. Decreased breathlessness on the basis of modified medical research council dyspnea scale [mMRC]
2. Improved health status and symptom relief based on COPD assessment scale [CAT]
3. Improved quality of life based on EQ-5D
4. Reduction in the number of incidents, hospital nights, the number of hospitalizations, outpatient contacts or the number of deaths related to COPD
5. A change in the classification of COPD severity based on GOLD A-D

Eligibility

Inclusion Criteria:

The patient is included in the study in connection with visits to COPD.

• Diagnosed COPD J44 (newly discovered or existing)
• Have completed the consent form
• Is judged to be able to handle the intervention himself or with the help of staff or relatives

Exclusion Criteria:

Patient who declines to participate in the trial.

• Impaired cognitive ability that is judged to affect the ability to conduct the study in the intended manner.
• Life expectancy <8 months
• In other ways, treating physicians are deemed to be inappropriate to participate in the study, e.g. due to participation in another study.